Ovation Science Inc. Stock price OTC Markets

Equities

OVATF

CA69016D1087

Biotechnology & Medical Research

Market Closed - OTC Markets 11:48:06 2024-02-13 am EST 5-day change 1st Jan Change
0.037 USD +43.05% Intraday chart for Ovation Science Inc. 0.00% +43.24%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
limited-time offer
Enjoy this offer
* See conditions on site
Sales 2021 225K 166K Sales 2022 138K 102K Capitalization 734K 541K
Net income 2021 -2M -1.47M Net income 2022 - 0 EV / Sales 2021 4.96 x
Net cash position 2021 648K 477K Net Debt 2022 12.23K 9.01K EV / Sales 2022 5.4 x
P/E ratio 2021
-0.74 x
P/E ratio 2022
-0.92 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 73.03%
More Fundamentals * Assessed data
Dynamic Chart
Ovation Science Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Ovation Science Inc. Signs License Agreement with Planet 13 Holdings, Inc CI
Ovation Science Inc. Announces Executive Changes CI
Ovation Science Inc. Announces Board Changes CI
Ovation Science Inc. announced that it has received CAD 0.2 million in funding CI
Ovation Science Inc. announced that it expects to receive CAD 0.2 million in funding CI
Ovation Science Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Ovation Science Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Ovation Science Inc. Signs Exclusive License Agreement for Its Topical Transdermal Cannabis Products for Pennsylvania CI
Ovation Science Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Ovation Science Announces International Supply and Distribution Agreement CI
Ovation Science Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Ovation Science Inc. Significantly Expands its Topical/Transdermal Cannabis Product Distribution in Four US States CI
Ovation Science Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Ovation Science Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
More news
1 day+43.05%
Current month+43.24%
1 month+43.24%
3 months-68.88%
6 months+1,384.00%
Current year+43.24%
More quotes
1 month
0.04
Extreme 0.03705
0.04
Current year
0.04
Extreme 0.03705
0.04
1 year
0.00
Extreme 0.0023
0.12
3 years
0.00
Extreme 0.0023
0.27
5 years
0.00
Extreme 0.0023
0.48
10 years
0.00
Extreme 0.0023
0.48
More quotes
Managers TitleAgeSince
Founder 61 17-07-17
Founder 75 17-07-17
Members of the board TitleAgeSince
Founder 75 17-07-17
Founder 61 17-07-17
Director/Board Member 57 18-02-01
More insiders
Ovation Science Inc. is a Canada-based research and development company. The Company develops topical and transdermal cannabidiol (CBD)/ tetrahydrocannabinol (THC) and other cannabinoid products which are out licensed and also distributed under its own brands; ARLO CBD Beauty and InVibe MD (wellness line); all powered by its patented Invisicare skin delivery technology. It manufactures, distributes, sells, markets, sub-licenses and promotes products formulated with Invisicare, containing cannabinoids, hemp seed oil or synthetic derivatives of cannabis. The Company has developed topical and transdermal creams and lotions made with CBD, THC and combinations thereof plus hemp seed oil. Invisicare is a patented polymer-based technology for topical and transdermal skin care products. ARLO CBD Beauty offers science-based skincare solutions. Invibe MD offers health and wellness products enhanced with hemp-derived CBD and delivered by patented Invisicare skin technology.
More about the company
  1. Stock
  2. Equities
  3. Stock Ovation Science Inc.
  4. Stock Ovation Science Inc. - OTC Markets
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW